EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 210 / Numéro 4 (2016) Biologie Aujourd'hui, 210 4 (2016) 171-189 Références
Accès gratuit
Numéro
Biologie Aujourd'hui
Volume 210, Numéro 4, 2016
Page(s) 171 - 189
Section Hypertension artérielle pulmonaire : une avancée thérapeutique
DOI https://doi.org/10.1051/jbio/2016022
Publié en ligne 22 mars 2017
  • Abdul, M., Hoosein, N. (2005). N-methyl-D-aspartate receptor in human prostate cancer. J Membr Biol, 205, 125-128. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Affaticati, P., Mignen, O., Jambou, F., Potier, M.-C., Klingel-Schmitt, I., Degrouard, J., Peineau, S., Gouadon, E., Collingridge, G.L., Liblau, R., Capiod, T., Cohen-Kaminsky, S. (2011). Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells. Cell Death Differ, 18, 99-108. [EDP Sciences] [PubMed] [Google Scholar]
  • Aldred, M.A., Comhair, S.A., Varella-Garcia, M., Asosingh, K., Xu, W., Noon G.P.,.Thistlethwaite, P.A., Tuder, R.M., Erzurum, S.C., Geraci, M.W., Coldren, C.D. (2010). Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med, 182, 1153-1160. [CrossRef] [PubMed] [Google Scholar]
  • Ali, S., Shourideh, M., Koochekpour, S. (2014). Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues. PloS One, 9, e103204. [PubMed] [Google Scholar]
  • András, I.E., Deli, M.A., Veszelka, S., Hayashi, K., Hennig, B., Toborek, M. (2007). The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab, 27, 1431-1443. [CrossRef] [PubMed] [Google Scholar]
  • Aronica, E., Yankaya, B., Jansen, G.H., Leenstra, S., van Veelen, C.W., Gorter, J.A., Troost, D. (2001). Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol, 27, 223-237. [PubMed] [Google Scholar]
  • Bai, L., Zhang, X., Ghishan, F.K. (2003). Characterization of vesicular glutamate transporter in pancreatic alpha- and beta-cells and its regulation by glucose. Am J Physiol Gastrointest Liver Physiol, 284, G808-G814. [PubMed] [Google Scholar]
  • Bertero, T., Oldham, W.M., Cottrill, K.A., Pisano, S., Vanderpool, R.R., Yu, Q., Zhao, J., Tai, Y., Tang, Y., Zhang, Y.-Y., Rehman, S., Sugahara, M., Qi, Z., Gorcsan, J., Vargas, S.O., Saggar, R., Saggar, R., Wallace, W.D., Ross, D.J., Haley, K.J., Waxman, A.B., Parikh, V.N., De Marco, T., Hsue, P.Y., Morris, A., Simon, M.A., Norris, K.A., Gaggioli, C., Loscalzo, J., Fessel, J., Chan, S.Y. (2016). Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest, 126, 3313-3335. [PubMed] [Google Scholar]
  • Bhangu, P.S., Genever, P.G., Spencer, G.J., Grewal, T.S., Skerry, T.M. (2001). Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone, 29, 16-23. [CrossRef] [PubMed] [Google Scholar]
  • Bussone, G., Tamby, M.C., Calzas, C., Kherbeck, N., Sahbatou, Y., Sanson, C., Ghazal, K., Dib, H., Weksler, B.B., Broussard, C., Verrecchia, F., Yaici, A., Witko-Sarsat, V., Simonneau, G., Guillevin, L., Humbert, M., Mouthon, L. (2012). IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction. Ann Rheum Dis, 71, 596-605. [CrossRef] [PubMed] [Google Scholar]
  • Cacoub, P., Dorent, R., Maistre, G., Nataf, P., Carayon, A., Piette, C., Godeau, P., Cabrol, C., Gandjbakhch, I. (1993). Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol, 71, 448-450. [CrossRef] [PubMed] [Google Scholar]
  • Casado, M., López-Guajardo, A., Mellström, B., Naranjo, J.R., Lerma, J. (1996). Functional N-methyl-D-aspartate receptors in clonal rat phaeochromocytoma cells. J Physiol, 490, 391-404. [CrossRef] [PubMed] [Google Scholar]
  • Chang, H.J., Yoo, B.C., Lim, S.-B., Jeong, S.-Y., Kim, W.H., Park, J.-G. (2005). Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res, 11, 3288-3295. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Chaumais, M.-C., Guignabert, C., Savale, L., Jaïs, X., Boucly, A., Montani D., Simonneau, G., Humbert, M., Sitbon, O. (2015). Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension. Am J Cardiovasc Drugs, 15, 13-26. [CrossRef] [PubMed] [Google Scholar]
  • Choi, C.H., Choi, J.-J., Park, Y.-A., Lee, Y.-Y., Song, S.Y., Sung, C.O., Song, T., Kim, M.-K., Kim, T.-J., Lee, J.-W., Kim, H.-J., Bae, D.-S., Kim, B.-G. (2012). Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival. Br J Cancer, 107, 91-99. [PubMed] [Google Scholar]
  • Choi, K.Y., Chang, K., Pickel, J.M., Badger, J.D., Roche, K.W. (2011). Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci, 108, 15219-15224. [CrossRef] [Google Scholar]
  • Cohen-Kaminsky, S., Hautefort, A., Price, L., Humbert, M., Perros, F. (2014).Inflammation in pulmonary hypertension: what we know and what we could logically and safely target first. Drug Discov Today, 19, 1251-1256. [CrossRef] [PubMed] [Google Scholar]
  • Courboulin, A., Paulin, R., Giguère, N.J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E.R., Biardel, S., Provencher, S., Cote, J., Simard, M.J., Bonnet, S. (2011). Role for miR-204 in human pulmonary arterial hypertension. J Exp Med, 208, 535-548. [CrossRef] [PubMed] [Google Scholar]
  • de Groot, J.F., Piao, Y., Lu, L., Fuller, G.N., Yung, W.K.A. (2008). Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol, 88, 121-133. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  • Doronzo, G., Russo, I., Del Mese, P., Viretto, M., Mattiello, L., Trovati, M., Anfossi, G. (2010). Role of NMDA receptor in homocysteine-induced activation of mitogen-activated protein kinase and phosphatidyl inositol 3-kinase pathways in cultured human vascular smooth muscle cells. Thromb Res, 125, e23-e32. [PubMed] [Google Scholar]
  • Drayton, R.M., Dudziec, E., Peter, S., Bertz, S., Hartmann, A., Bryant, H.E., Catto, J.W. (2014). Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11. Clin Cancer Res, 20, 1990-2000. [CrossRef] [PubMed] [Google Scholar]
  • Duong-Quy, S., Bei, Y., Liu, Z., Dinh-Xuan, A.T. (2013). Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacol Ther, 137, 352-364. [PubMed] [Google Scholar]
  • Elgadi, K.M., Meguid, R.A., Qian, M., Souba, W.W., Abcouwer, S.F. (1999). Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics, 1, 51-62. [CrossRef] [PubMed] [Google Scholar]
  • Erickson, J.W., Cerione, R.A. (2010). Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism? Oncotarget, 1, 734-740. [PubMed] [Google Scholar]
  • Esseltine, J.L., Willard, M.D., Wulur, I.H., Lajiness, M.E., Barber, T.D., Ferguson, S.S.G. (2013). Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling. Mol Pharmacol, 83, 770-780. [PubMed] [Google Scholar]
  • Evans, J.D.W., Girerd, B., Montani, D., Wang, X.-J., Galiè, N., Austin, E.D., Elliott, G., Asano, K., Grünig, E., Yan, Y., Jing, Z.-C., Manes, A., Palazzini, M., Wheeler, L.A., Nakayama, I., Satoh, T., Eichstaedt, C., Hinderhofer, K., Wolf; M., Rosenzweig, E.B., Chung, W.K., Soubrier, F., Simonneau, G., Sitbon, O., Gräf, S., Kaptoge, S., Di Angelantonio, E., Humbert, M., Morrell, N.W. (2016). BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med, 4, 129-137. [Google Scholar]
  • Fukumoto, Y., Yamada, N., Matsubara, H., Mizoguchi, M., Uchino, K., Yao, A., Kihara, Y., Kawano, M., Watanabe, H., Takeda, Y., Adachi, T., Osanai, S., Tanabe, N., Inoue, T., Kubo, A., Ota, Y., Fukuda, K., Nakano, T., Shimokawa, H. (2013). Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension. Circ J, 77, 2619-2625. [PubMed] [Google Scholar]
  • Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., GomezSanchez, M.A., Hansmann, G., Klepetko, W., Lancellotti, P., Matucci, M., McDonagh, T., Pierard, L.A., Trindade, P.T., Zompatori, M., Hoeper, M. (2015). ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension. Eur Respir J, 46, 903-975. [CrossRef] [PubMed] [Google Scholar]
  • Ganor, Y., Grinberg, I., Reis, A., Cooper, I., Goldstein, R.S., Levite, D.M. (2009). Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo. Leuk Lymphoma, 50, 985-997. [PubMed] [Google Scholar]
  • George, M.P., Champion, H.C., Pilewski, J.M. (2011). Lung transplantation for pulmonary hypertension. Pulm Circ, 1, 182-191. [CrossRef] [PubMed] [Google Scholar]
  • Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem, 273, 30336-30343. [CrossRef] [PubMed] [Google Scholar]
  • Gillard, S.E., Tzaferis, J., Tsui, H.-C.T., Kingston, A.E. (2003). Expression of metabotropic glutamate receptors in rat meningeal and brain microvasculature and choroid plexus. J Comp Neurol, 461, 317-332. [PubMed] [Google Scholar]
  • Gill, S.S., Pulido, O.M. (2001). Glutamate Receptors in Peripheral Tissues: Current Knowledge, Future Research, and Implications for Toxicology. Toxicol Pathol, 29, 208-223. [CrossRef] [PubMed] [Google Scholar]
  • Gross, M.I., Demo, S.D., Dennison, J.B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J.R., Laidig, G.J., Lewis, E.R., Li, J., Mackinnon, A.L., Parlati, F., Rodriguez, M.L.M., Shwonek, P.J., Sjogren, E.B., Stanton, T.F., Wang, T., Yang, J., Zhao, F., Bennett, M.K. (2014). Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther, 13, 890-901. [CrossRef] [PubMed] [Google Scholar]
  • Guignabert, C., Tu, L., Izikki, M., Dewachter, L., Zadigue, P., Humbert, M., Adnot, S., Fadel, E., Eddahibi, S. (2009). Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22α-targeted overexpression of the serotonin transporter. FASEB J, 23, 4135-4147. [CrossRef] [PubMed] [Google Scholar]
  • Guignabert, C., Tu, L., Hiress, M.L., Ricard, N., Sattler, C., Seferian, A., Huertas, A., Humbert, M., Montani, D. (2013). Pathogenesis of pulmonary arterial hypertension: lessons from cancer. Eur Respir Rev, 22, 543-551. [CrossRef] [PubMed] [Google Scholar]
  • Hanahan, D., Weinberg, R.A. (2000). The hallmarks of cancer. Cell, 100, 57-70. [CrossRef] [PubMed] [Google Scholar]
  • Hanahan, D., Weinberg, R.A. (2011). Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [CrossRef] [PubMed] [Google Scholar]
  • Hasegawa, M., Takahashi, H., Rajabi, H., Alam, M., Suzuki, Y., Yin, L., Tagde, A., Maeda, T., Hiraki, M., Sukhatme, V.P., Kufe, D. (2016). Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget, 7, 11756-11769. [PubMed] [Google Scholar]
  • Hassanein, M., Hoeksema, M.D., Shiota, M., Qian, J., Harris, B.K., Chen, H., Clark, J.E., Alborn, W.E., Eisenberg, R., Massion, P.P. (2013). SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival. Clin Cancer Res, 19, 560-570. [CrossRef] [PubMed] [Google Scholar]
  • Hassanein, M., Qian, J., Hoeksema, M.D., Wang, J., Jacobovitz, M., Ji, X., Harris, F.T., Harris, B.K., Boyd, K.L., Chen, H., Eisenberg, R., Massion, P.P. (2015). Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. Int J Cancer, 137, 1587-1597. [CrossRef] [PubMed] [Google Scholar]
  • Herner, A., Sauliunaite, D., Michalski, C.W., Erkan, M., Oliveira, T.D., Abiatari, I., Kong, B., Esposito, I., Friess, H., Kleeff, J. (2011). Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling. Int J Cancer, 129, 2349-2359. [CrossRef] [PubMed] [Google Scholar]
  • Herranz, D., Ambesi-Impiombato, A., Sudderth, J., Sánchez-Martín, M., Belver, L., Tosello, V., Xu, L., Wendorff, A.A., Castillo, M., Haydu, J.E., Márquez, J., Matés, J.M., Kung, A.L., Rayport, S., Cordon-Cardo, C., DeBerardinis, R.J., Ferrando, A.A. (2015). Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med, 21, 1182-1189. [CrossRef] [PubMed] [Google Scholar]
  • Hinoi, E., Takarada, T., Ueshima, T., Tsuchihashi, Y., Yoneda, Y. (2003). Glutamate signaling in peripheral tissues: Glutamate signaling in peripheral tissues. Eur J Biochem, 271, 1-13. [Google Scholar]
  • Hoeper, M.M., Lee, S.H., Voswinckel, R., Palazzini, M., Jais, X., Marinelli, A., Barst, R.J., Ghofrani, H.A., Jing, Z.-C., Opitz, C., Seyfarth, H.-J., Halank, M., McLaughlin, V., Oudiz, R.J., Ewert, R., Wilkens, H., Kluge, S., Bremer, H.-C., Baroke, E., Rubin, L.J. (2006). Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol, 48, 2546-2552. [CrossRef] [PubMed] [Google Scholar]
  • Hoeper, M.M., Barst, R.J., Bourge, R.C., Feldman, J., Frost, A.E., Galiè, N., Gómez-Sánchez, M.A., Grimminger, F., Grünig, E., Hassoun, P.M., Morrell, N.W., Peacock, A.J., Satoh, T., Simonneau, G., Tapson, V.F., Torres, F., Lawrence, D., Quinn, D.A., Ghofrani, H.-A. (2013). Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation, 127, 1128-1138. [CrossRef] [PubMed] [Google Scholar]
  • Huertas, A., Perros, F., Tu, L., Cohen-Kaminsky, S., Montani, D., Dorfmüller P.,Guignabert, C., Humbert, M. (2014). Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension A Complex Interplay. Circulation, 129, 1332-1340. [CrossRef] [PubMed] [Google Scholar]
  • Hu, H., Takano, N., Xiang, L., Gilkes, D.M., Luo, W., Semenza, G.L. (2014). Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget, 5, 8853. [PubMed] [Google Scholar]
  • Humbert, M. (2013). Impression, Sunset. Circulation, 127, 1098-1100. [CrossRef] [PubMed] [Google Scholar]
  • Humbert, M., Ghofrani, H.-A. (2016). The molecular targets of approved treatments for pulmonary arterial hypertension. Thorax, 71, 73-83. [CrossRef] [PubMed] [Google Scholar]
  • Humbert, M., Sitbon, O., Simonneau, G. (2004).Treatment of Pulmonary Arterial Hypertension. N Engl J Med, 351, 1425-1436. [CrossRef] [PubMed] [Google Scholar]
  • Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., Dromer, C., Pison; C., Reynaud-Gaubert, M., Haloun, A., Laurent, M., Hachulla, E., Cottin, V., Degano, B., Jaïs, X., Montani, D., Souza, R., Simonneau, G. (2010). Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation, 122, 156-163. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Iacovelli, L., Arcella, A., Battaglia, G., Pazzaglia, S., Aronica, E., Spinsanti, P., Caruso, A., De Smaele, E., Saran, A., Gulino, A., D’Onofrio, M., Giangaspero, F., Nicoletti, F. (2006). Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J Neurosci, 26, 8388-8397. [CrossRef] [PubMed] [Google Scholar]
  • Ibragimova, I., Slifker, M.J., Maradeo, M.E., Banumathy, G., Dulaimi, E., Uzzo, R.G., Cairns, P. (2013). Genome-Wide Promoter Methylome of Small Renal Masses. PLOS ONE, 8, e77309. [PubMed] [Google Scholar]
  • Ishiuchi, S., Tsuzuki, K., Yoshida, Y., Yamada, N., Hagimura, N., Okado, H., Miwa, A., Kurihara, H., Nakazato, Y., Tamura, M., Sasaki, T., Ozawa, S. (2002). Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med, 8, 971-978. [CrossRef] [PubMed] [Google Scholar]
  • Izikki, M., Hoang, E., Draskovic, I., Mercier, O., Lecerf, F., Lamrani, L., Liu, W.-Y., Guignabert, C., Fadel, E., Dorfmuller, P., Humbert, M., Londoño-Vallejo, A., Eddahibi, S. (2015). Telomere Maintenance Is a Critical Determinant in the Physiopathology of Pulmonary Hypertension. J Am Coll Cardiol, 66, 1942-1943. [CrossRef] [PubMed] [Google Scholar]
  • Jin, L., Alesi, G.N., Kang, S. (2016). Glutaminolysis as a target for cancer therapy. Oncogene, 35, 3619-3625. [CrossRef] [PubMed] [Google Scholar]
  • Julio-Pieper, M., Flor, P.J., Dinan, T.G., Cryan, J.F. (2011). Exciting Times beyond the Brain: Metabotropic Glutamate Receptors in Peripheral and Non-Neural Tissues. Pharmacol Rev, 63, 35-58. [CrossRef] [PubMed] [Google Scholar]
  • Kalariti, N., Lembessis, P., Koutsilieris, M. (2011). Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells. Anticancer Res, 24, 3923-3929. [Google Scholar]
  • Kan, Z., Jaiswal, B.S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H.M., Yue, P., Haverty, P.M., Bourgon, R., Zheng, J., Moorhead, M., Chaudhuri, S., Tomsho, L.P., Peters, B.A., Pujara, K., Cordes, S., Davis, D.P., Carlton, V.E.H., Yuan, W., Li, L., Wang, W., Eigenbrot, C., Kaminker, J.S., Eberhard, D.A., Waring, P., Schuster, S.C., Modrusan, Z., Zhang, Z., Stokoe, D., de Sauvage, F.J., Faham, M., Seshagiri, S. (2010). Diverse somatic mutation patterns and pathway alterations in human cancers. Nature, 466, 869-873. [CrossRef] [PubMed] [Google Scholar]
  • Kasatkina, L.A., Borisova, T.A. (2013). Glutamate release from platelets: Exocytosis versus glutamate transporter reversal. Int J Biochem Cell Biol, 45, 2585-2595. [CrossRef] [PubMed] [Google Scholar]
  • Kim, M.S., Yamashita, K., Chae, Y.K., Tokumaru, Y., Chang, X., Zahurak, M., Osada, M., Park, H.L., Chuang, A., Califano, J.A., Sidransky, D. (2007). A Promoter Methylation Pattern in the N-Methyl-d-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma. Clin Cancer Res, 13, 6658-6665. [CrossRef] [PubMed] [Google Scholar]
  • Kim, M.S., Chang, X., Nagpal, J.K., Yamashita, K., Baek, J.H., Dasgupta, S., Wu, G., Osada, M., Woo, J.-H., Westra, W.H., Trink, B., Ratovitski, E.A., Moon, C., Sidransky, D. (2008). The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene, 27, 2045-2054. [CrossRef] [PubMed] [Google Scholar]
  • Koochekpour, S., Majumdar, S., Azabdaftari, G., Attwood, K., Scioneaux, R., Subramani, D., Manhardt, C., Lorusso, G.D., Willard, S.S., Thompson, H., Shourideh, M., Rezaei, K., Sartor, O., Mohler, J.L., Vessella, R.L. (2012). Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells. Clin Cancer Res, 18, 5888-5901. [CrossRef] [PubMed] [Google Scholar]
  • Koochekpour, S. (2013). Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. Asian J Androl, 15, 212-213. [PubMed] [Google Scholar]
  • Korczak, B., McWhinnie, E.A., Fletcher, E.J., Kamboj, R.K. (1995). Expression of human glutamate receptors (GluR) in neuroblastoma cell lines. Neuroreport, 6, 905-909. [CrossRef] [PubMed] [Google Scholar]
  • Krizbai, I.A., Deli, M.A., Pestenácz, A., Siklós, L., Szabó, C.A., András, I., Joó, F. (1998). Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res, 54, 814-819. [CrossRef] [PubMed] [Google Scholar]
  • Kuribayashi, N., Uchida, D., Kinouchi, M., Takamaru, N., Tamatani, T., Nagai, H., Miyamoto, Y. (2013). The Role of Metabotropic Glutamate Receptor 5 on the Stromal Cell-Derived Factor-1/CXCR4 System in Oral Cancer. PLoS ONE, 8, e80773. [PubMed] [Google Scholar]
  • Lang, I.M., Gaine, S.P. (2015). Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension. Eur Respir Rev, 24, 630-641. [CrossRef] [PubMed] [Google Scholar]
  • Lee, S.D., Shroyer, K.R., Markham, N.E., Cool, C.D., Voelkel, N.F., Tuder, R.M. (1998). Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest, 101, 927-934. [PubMed] [Google Scholar]
  • Le, M.N., Chan, J.L.-K., Rosenberg, S.A., Nabatian, A.S., Merrigan, K.T., Cohen-Solal, K.A., Goydos, J.S. (2010). The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol, 130, 2240-2249. [PubMed] [Google Scholar]
  • Liang, H., Cheung, L.W.T., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., Dogruluk, T., Lu, Y., Liu, X., Gu, C., Guo, W., Scherer, S.E., Carter, H., Westin, S.N., Dyer, M.D., Verhaak, R.G.W., Zhang, F., Karchin, R., Liu, C.-G., Lu, K.H., Broaddus, R.R., Scott, K.L., Hennessy, B.T., Mills, G.B. (2012). Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res, 22, 2120-2129. [CrossRef] [PubMed] [Google Scholar]
  • Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.-X., Foo, J.N., McLaren, P.J., Li, Z., Yang, J., Shen, F., Liu, L., Yang, J., Li, S., Pan, S., Wang, Y., Li, W., Zhai, X., Zhou, B., Shi, L., Chen, X., Chu, M., Yan, Y., Wang, J., Cheng, S., Shen, J., Jia, W., Liu, J., Yang, J., Wen, Z., Li, A., Zhang, Y., Zhang, G., Luo, X., Qin, H., Chen, M., Wang, H., Jin, L., Lin, D., Shen, H., He, L., de Bakker, P.I.W., Wang, H., Zeng, Y.-X., Wu, M., Hu, Z., Shi, Y., Liu, J., Zhou, W. (2012). GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet, 8, e1002791. [CrossRef] [PubMed] [Google Scholar]
  • Li, L., Hanahan, D. (2013). Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion. Cell, 153, 86-100. [PubMed] [Google Scholar]
  • Liu, J.-W., Kim, M.S., Nagpal, J., Yamashita, K., Poeta, L., Chang, X., Lee, J., Park, H.L., Jeronimo, C., Westra, W.H., Mori, M., Moon, C., Trink, B., Sidransky, D. (2007). Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J Cancer, 121, 1994-2000. [CrossRef] [PubMed] [Google Scholar]
  • Luksch, H., Uckermann, O., Stepulak, A., Hendruschk, S., Marzahn, J., Bastian, S., Staufner, C., Temme, A., Ikonomidou, C. (2011). Silencing of Selected Glutamate Receptor Subunits Modulates Cancer Growth. Anticancer Res, 31, 3181-3192. [PubMed] [Google Scholar]
  • Lyons, S.A., Chung, W.J., Weaver, A.K., Ogunrinu, T., Sontheimer, H. (2007). Autocrine Glutamate Signaling Promotes Glioma Cell Invasion. Cancer Res, 67, 9463-9471. [Google Scholar]
  • Marín, Y.E., Chen, S. (2004). Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. J Mol Med Berl Ger, 82, 735-749. [CrossRef] [MathSciNet] [Google Scholar]
  • Martino, J.J., Wall, B.A., Mastrantoni, E., Wilimczyk, B.J., La Cava, S.N., Degenhardt, K., White, E., Chen, S. (2013). Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells. Oncogene, 32, 4366-4376. [CrossRef] [PubMed] [Google Scholar]
  • McMurtry, M.S., Bonnet, S., Wu, X., Dyck, J.R.B., Haromy, A., Hashimoto, K., Michelakis, E.D. (2004). Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis. Circ Res, 95, 830-840. [Google Scholar]
  • McMurtry, M.S., Moudgil, R., Hashimoto, K., Bonnet, S., Michelakis, E.D., Archer, S.L. (2007). Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension. Am J Physiol - Lung Cell Mol Physiol, 292, L872-L878. [CrossRef] [Google Scholar]
  • Mehta, M.S., Dolfi, S.C., Bronfenbrener, R., Bilal, E., Chen, C., Moore, D., Lin, Y., Rahim, H., Aisner, S., Kersellius, R.D., Teh, J., Chen, S., Toppmeyer, D.L., Medina, D.J., Ganesan, S., Vazquez, A., Hirshfield, K.M. (2013). Metabotropic Glutamate Receptor 1 Expression and Its Polymorphic Variants Associate with Breast Cancer Phenotypes. PLoS ONE, 8, e69851. [PubMed] [Google Scholar]
  • Meloche, J., Pflieger, A., Vaillancourt, M., Paulin, R., Potus, F., Zervopoulos, S., Graydon, C., Courboulin, A., Breuils-Bonnet, S., Tremblay, E., Couture, C., Michelakis, E.D., Provencher, S., Bonnet, S. (2014). Role for DNA damage signaling in pulmonary arterial hypertension. Circulation, 129, 786-797. [CrossRef] [PubMed] [Google Scholar]
  • Michelakis, E.D., McMurtry, M.S., Wu, X.-C., Dyck, J.R.B., Moudgil, R., Hopkins, T.A., Lopaschuk, G.D., Puttagunta, L., Waite, R., Archer, S.L. (2002). Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation, 105, 244-250. [CrossRef] [PubMed] [Google Scholar]
  • Mizuno, S., Bogaard, H.J., Kraskauskas, D., Alhussaini, A., Gomez-Arroyo, J., Voelkel, N.F., Ishizaki, T. (2011). p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol-Lung Cell Mol Physiol, 300, L753-761. [CrossRef] [Google Scholar]
  • Montani, D., Perros, F., Gambaryan, N., Girerd, B., Dorfmuller, P., Price, L.C., Huertas, A., Hammad, H., Lambrecht, B., Simonneau, G., Launay, J.M., Cohen-Kaminsky, S., Humbert, M. (2011). C-Kit-Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension. Am J Respir Crit Care Med, 184, 116-23. [CrossRef] [PubMed] [Google Scholar]
  • Morimoto, R., Uehara, S., Yatsushiro, S., Juge, N., Hua, Z., Senoh, S., Echigo, N., Hayashi, M., Mizoguchi, T., Ninomiya, T., Udagawa, N., Omote, H., Yamamoto, A., Edwards, R.H., Moriyama, Y. (2006). Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J, 25, 4175-4186. [PubMed] [Google Scholar]
  • Moriyama, Y., Yamamoto, A. (2004). Glutamatergic Chemical Transmission: Look! Here, There, and Anywhere. J Biochem (Tokyo), 135, 155-163. [CrossRef] [Google Scholar]
  • Morrison, C.D., Liu, P., Woloszynska-Read, A., Zhang, J., Luo, W., Qin, M., Bshara, W., Conroy, J.M., Sabatini, L., Vedell, P., Xiong, D., Liu, S., Wang, J., Shen, H., Li, Y., Omilian, A.R., Hill, A., Head, K., Guru, K., Kunnev, D., Leach, R., Eng, K.H., Darlak, C., Hoeflich, C., Veeranki, S., Glenn, S., You, M., Pruitt, S.C., Johnson, C.S., Trump, D.L. (2014). Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer. Proc Natl Acad Sci USA, 111, E672-E681. [CrossRef] [Google Scholar]
  • Mouraret, N., Marcos, E., Abid, S., Gary-Bobo, G., Saker, M., Houssaini, A., Dubois-Rande, J.-L., Boyer, L., Boczkowski, J., Derumeaux, G., Amsellem, V., Adnot, S. (2013). Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension. Circulation, 127, 1664-1676. [CrossRef] [PubMed] [Google Scholar]
  • Mouraret, N., Houssaïni, A., Abid, S., Quarck, R., Marcos, E., Parpaleix, A., Gary-Bobo, G., Dubois-Randé, J.-L., Derumeaux, G., Boczkowski, J., Delcroix, M., Blasco, M.A., Lipskaia, L., Amsellem, V., Adnot, S. (2015). Role for telomerase in pulmonary hypertension. Circulation, 131, 742-755. [CrossRef] [PubMed] [Google Scholar]
  • Naarala, J., Nykvist, P., Tuomala, M., Savolainen, K.V. (1993). Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett, 330, 222-226. [CrossRef] [PubMed] [Google Scholar]
  • Namkoong, J., Shin, S.-S., Lee, H.J., Marín, Y.E., Wall, B.A., Goydos, J.S., Chen, S. (2007). Metabotropic Glutamate Receptor 1 and Glutamate Signaling in Human Melanoma. Cancer Res, 67, 2298-2305. [Google Scholar]
  • North, W.G., Gao, G., Jensen, A., Memoli, V.A., Du, J. (2010a). NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment. Clin Pharmacol Adv Appl, 2, 31-40. [Google Scholar]
  • North, W.G., Gao, G., Memoli, V.A., Pang, R.H., Lynch, L. (2010b). Breast cancer expresses functional NMDA receptors. Breast Cancer Res Treat, 122, 307-314. [CrossRef] [PubMed] [Google Scholar]
  • North, W., Liu, F., Tian, R., Abbasi, H., Akerman, B. (2015). NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines. Clin Pharmacol Adv Appl, 7, 111-117. [Google Scholar]
  • O’Callaghan, D.S., Savale, L., Montani, D., Jaïs, X., Sitbon, O., Simonneau, G., Humbert, M. (2011). Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol, 8, 526-538. [CrossRef] [PubMed] [Google Scholar]
  • Ohkuma, S., Katsura, M., Chen, D.Z., Chen, S.H., Kuriyama, K. (1994). Presence of N-methyl-D-aspartate (NMDA) receptors in neuroblastoma x glioma hybrid NG108-15 cells-analysis using [45Ca2+]influx and [3H]MK-801 binding as functional measures. Brain Res Mol Brain Res, 22, 166-172. [CrossRef] [PubMed] [Google Scholar]
  • Ohtani, Y., Harada, T., Funasaka, Y., Nakao, K., Takahara, C., Abdel-Daim, M., Sakai, N., Saito, N., Nishigori, C., Aiba, A. (2008). Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma. Oncogene, 27, 7162-7170. [CrossRef] [PubMed] [Google Scholar]
  • Park, S.-Y., Lee, S.-A., Han, I.-H., Yoo, B.-C., Lee, S.-H., Park, J.-Y., Cha, I.-H., Kim, J., Choi, S.-W. (2007). Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep, 17, 81-87. [PubMed] [Google Scholar]
  • Paulin, R., Michelakis, E.D. (2014). The metabolic theory of pulmonary arterial hypertension. Circ Res, 115, 148-164. [Google Scholar]
  • Perrin, S., Chaumais, M.-C., O’Connell, C., Amar, D., Savale, L., Jaïs, X., Montani, D., Humbert, M., Simonneau, G., Sitbon, O. (2015). New pharmacotherapy options for pulmonary arterial hypertension. Expert Opin Pharmacother, 16, 2113-2131. [CrossRef] [PubMed] [Google Scholar]
  • Perros,, F., Montani,, D., Dorfmüller, P., Durand-Gasselin, I., Tcherakian, C., Le Pavec, J., Mazmanian, M., Fadel, E., Mussot, S., Mercier, O., Hervé, P., Emilie, D., Eddahibi, S., Simonneau, G., Souza, R., Humbert, M. (2008). Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 178, 81-88. [CrossRef] [PubMed] [Google Scholar]
  • Perros, F., Dorfmüller, P., Montani, D., Hammad, H., Waelput, W., Girerd, B., Raymond, N., Mercier, O., Mussot, S., Cohen-Kaminsky, S., Humbert, M., Lambrecht, B.N. (2012). Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med, 185, 311-321. [CrossRef] [PubMed] [Google Scholar]
  • Piao, L., Fang, Y.-H., Parikh, K., Ryan, J.J., Toth, P.T., Archer, S.L. (2013). Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension. J Mol Med Berl Ger, 91, 1185-1197. [CrossRef] [Google Scholar]
  • Pissimissis, N., Papageorgiou, E., Lembessis, P., Armakolas, A., Koutsilieris, M. 2009. The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells. Anticancer Res, 29, 371-377. [PubMed] [Google Scholar]
  • Pollock, P.M., Cohen-Solal, K., Sood, R., Namkoong, J., Martino, J.J., Koganti, A., Zhu,, H., Robbins, C., Makalowska, I., Shin, S.-S., Marin, Y., Roberts, K.G., Yudt, L.M., Chen, A., Cheng, J., Incao, A., Pinkett, H.W., Graham, C.L., Dunn, K., Crespo-Carbone, S.M., Mackason, K.R., Ryan, K.B., Sinsimer, D., Goydos, J., Reuhl, K.R., Eckhaus, M., Meltzer, P.S., Pavan, W.J., Trent, J.M., Chen, S. (2003). Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet, 34, 108-112. [CrossRef] [PubMed] [Google Scholar]
  • Prickett, T.D., Samuels, Y. (2012). Molecular pathways: dysregulated glutamatergic signaling pathways in cancer. Clin Cancer Res, 18, 4240-4246. [CrossRef] [PubMed] [Google Scholar]
  • Prickett, T.D., Wei, X., Cardenas-Navia, I., Teer, J.K., Lin, J.C., Walia, V., Gartner, J., Jiang, J., Cherukuri, P.F., Molinolo, A., Davies, M.A., Gershenwald J.E., Stemke-Hale, K., Rosenberg, S.A., Margulies, E.H., Samuels, Y. (2011). Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet, 43, 1119-1126. [CrossRef] [PubMed] [Google Scholar]
  • Qureshi, I., Chen, H., Brown, A.T., Fitzgerald, R., Zhang, X., Breckenridge, J., Kazi, R., Crocker, A.J., Stühlingexsr, M.C., Lin, K., Cooke, J.P., Eidt, J.F., Moursi, M.M. (2005). Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vasc Med, 10, 215-223. [CrossRef] [PubMed] [Google Scholar]
  • Rabinovitch, M., Guignabert, C., Humbert, M., Nicolls, M.R. (2014). Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension. Circ Res, 115, 165-175. [Google Scholar]
  • Rai, P.R., Cool, C.D., King, J.A.C., Stevens, T., Burns, N., Winn, R.A., Kasper, M., Voelkel, N.F. (2008). The Cancer Paradigm of Severe Pulmonary Arterial Hypertension. Am J Respir Crit Care Med, 178, 558-564. [CrossRef] [PubMed] [Google Scholar]
  • Ranchoux, B., Antigny, F., Rucker-Martin, C., Hautefort, A., Péchoux, C., Bogaard, H.J., Dorfmüller, P., Remy, S., Lecerf, F., Planté S., Chat, S., Fadel, E., Houssaini, A., Anegon, I., Adnot, S., Simonneau, G., Humbert, M., Cohen-Kaminsky, S., Perros, F. (2015). Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation, 131, 1006-1018. [CrossRef] [PubMed] [Google Scholar]
  • Redecker, P., Kreutz, M.R., Bockmann, J., Gundelfinger, E.D., Boeckers, T.M. (2003). Brain Synaptic Junctional Proteins at the Acrosome of Rat Testicular Germ Cells. J Histochem Cytochem, 51, 809-819. [CrossRef] [PubMed] [Google Scholar]
  • Ripka, S., Riedel, J., Neesse, A., Griesmann, H., Buchholz, M., Ellenrieder, V., Moeller, F., Barth, P., Gress, T.M., Michl, P. (2010). Glutamate Receptor GRIA3–Target of CUX1 and Mediator of Tumor Progression in Pancreatic Cancer. Neoplasia NYN, 12, 659-667. [CrossRef] [Google Scholar]
  • Rzeski, W., Turski, L., Ikonomidou, C. (2001). Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA, 98, 6372-6377. [CrossRef] [Google Scholar]
  • Savage, S.A., Mirabello, L., Wang, Z., Gastier-Foster, J.M., Gorlick, R., Khanna, C., Flanagan, A.M., Tirabosco, R., Andrulis, I.L., Wunder, J.S., Gokgoz, N., Patiño-Garcia, A., Sierrasesúmaga, L., Lecanda, F., Kurucu, N., Ilhan, I.E., Sari, N., Serra, M., Hattinger, C., Picci, P., Spector, L.G., Barkauskas, D.A., Marina, N., de Toledo, S.R.C., Petrilli, A.S., Amary, M.F., Halai, D., Thomas, D.M., Douglass, C., Meltzer, P.S., Jacobs, K., Chung, C.C., Berndt, S.I., Purdue, M.P., Caporaso, N.E., Tucker, M., Rothman, N., Landi, M.T., Silverman, D.T., Kraft, P., Hunter, D.J., Malats, N., Kogevinas, M., Wacholder, S., Troisi, R., Helman, L., Fraumeni, J.F., Yeager, M., Hoover, R.N., Chanock, S.J. (2013). Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet, 45, 799-803. [CrossRef] [PubMed] [Google Scholar]
  • Schermuly, R.T., Dony, E., Ghofrani, H.A., Pullamsetti, S., Savai, R., Roth, M., Sydykov, A., Lai, Y.J., Weissmann, N., Seeger, W., Grimminger, F. (2005). Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest, 115, 2811-2821. [PubMed] [Google Scholar]
  • Sharma, M.K., Seidlitz, E.P., Singh, G. (2010). Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun, 391, 91-95. [CrossRef] [PubMed] [Google Scholar]
  • Sinclair, P.B., Sorour, A., Martineau, M., Harrison, C.J., Mitchell, W.A., O’Neill, E., Foroni, L. (2004). A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res, 64, 4089-4098. [Google Scholar]
  • Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E.A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., Montani, D., Humbert, M., Simonneau, G. (2014a). Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J, 43, 1691-1697. [PubMed] [Google Scholar]
  • Sitbon, O., Savale, L., Jaïs, X., Montani, D., Humbert, M., Simonneau, G. (2014b). Traitement de l’hypertension artérielle pulmonaire. Presse Médicale, 43, 981-993. [CrossRef] [Google Scholar]
  • Soria, F.N., Pérez-Samartín, A., Martin, A., Gona, K.B., Llop, J., Szczupak, B., Chara, J.C., Matute, C., Domercq, M. (2014). Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J Clin Invest, 124, 3645-3655. [PubMed] [Google Scholar]
  • Speyer, C.L., Smith, J.S., Banda, M., DeVries, J.A., Mekani, T., Gorski, D.H. 2011. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat, 132, 565-573. [CrossRef] [PubMed] [Google Scholar]
  • Stepulak, A., Sifringer, M., Rzeski, W., Endesfelder, S., Gratopp, A., Pohl, E.E., Bittigau, P., Felderhoff-Mueser, U., Kaindl, A.M., Bührer, C., Hansen, H.H., Stryjecka-Zimmer, M., Turski, L., Ikonomidou, C. (2005). NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA, 102, 15605-15610. [CrossRef] [Google Scholar]
  • Stepulak, A., Luksch, H., Gebhardt, C., Uckermann, O., Marzahn, J., Sifringer, M., Rzeski, W., Staufner, C., Brocke, K.S., Turski, L., Ikonomidou, C. (2009). Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol, 132, 435-445. [CrossRef] [PubMed] [Google Scholar]
  • Stepulak, A., Luksch, H., Uckermann, O., Sifringer, M., Rzeski, W., Polberg, K., Kupisz, K., Klatka, J., Kiełbus, M., Grabarska, A., Marzahn, J., Turski, L., Ikonomidou, C. (2011). Glutamate Receptors in Laryngeal Cancer Cells. Anticancer Res, 31, 565-573. [PubMed] [Google Scholar]
  • Takano, T., Lin, J.H.-C., Arcuino, G., Gao, Q., Yang, J., Nedergaard, M. (2001). Glutamate release promotes growth of malignant gliomas. Nat Med, 7, 1010-1015. [CrossRef] [PubMed] [Google Scholar]
  • Tamura, H., Suzuki, M., Moriya, Y., Hoshino, H., Okamoto, T., Yoshida, S., Yoshino, I. (2011). Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma. BMC Cancer, 11, 220. [CrossRef] [PubMed] [Google Scholar]
  • Tanaka, K., Sasayama, T., Irino, Y., Takata, K., Nagashima, H., Satoh, N., Kyotani, K., Mizowaki, T., Imahori, T., Ejima, Y., Masui, K., Gini, B., Yang, H., Hosoda, K., Sasaki, R., Mischel, P.S., Kohmura, E. (2015). Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J Clin Invest, 125, 1591-1602. [PubMed] [Google Scholar]
  • Tremolizzo, L., DiFrancesco, J.C., Rodriguez-Menendez, V., Sirtori, E., Longoni, M., Cassetti, A., Bossi, M., El Mestikawy, S., Cavaletti, G., Ferrarese, C. (2006). Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation. Neurosci Lett, 404, 262-265. [CrossRef] [PubMed] [Google Scholar]
  • Tuder, R.M., Chacon, M., Alger, L., Wang, J., Taraseviciene-Stewart, L., Kasahara, Y., Cool, C.D., Bishop, A.E., Geraci, M., Semenza, G.L., Yacoub, M., Polak, J.M., Voelkel, N.F. (2001). Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol, 195, 367-374. [PubMed] [Google Scholar]
  • Tu, L., Dewachter, L., Gore, B., Fadel, E., Dartevelle, P., Simonneau, G., Humbert, M., Eddahibi, S., Guignabert, C. (2011). Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am J Respir Cell Mol Biol, 45, 311-322. [CrossRef] [PubMed] [Google Scholar]
  • Wang, J.-B., Erickson, J.W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K.F., Ambrosio, A.L.B., Dias, S.M.G., Dang, C.V., Cerione, R.A. (2010). Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation. Cancer Cell, 18, 207-219. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Wang, Q., Beaumont, K.A., Otte, N.J., Font, J., Bailey, C.G., van Geldermalsen, M., Sharp, D.M., Tiffen, J.C., Ryan, R.M., Jormakka, M., Haass, N.K., Rasko, J.E.J., Holst, J. (2014). Targeting glutamine transport to suppress melanoma cell growth. Int J Cancer, 135, 1060-1071. [CrossRef] [PubMed] [Google Scholar]
  • Watanabe, K., Kanno, T., Oshima, T., Miwa, H., Tashiro, C., Nishizaki, T. (2008). The NMDA receptor NR2A subunit regulates proliferation of MKN45 human gastric cancer cells. Biochem Biophys Res Commun, 367, 487-490. [CrossRef] [PubMed] [Google Scholar]
  • Wei, X., Walia, V., Lin, J.C., Teer, J.K., Prickett, T.D., Gartner, J., Davis, S., NISC Comparative Sequencing Program,Stemke-Hale, K., Davies, M.A., Gershenwald, J.E., Robinson, W., Robinson, S., Rosenberg, S.A., Samuels, Y. (2011). Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet, 43, 442-446. [CrossRef] [PubMed] [Google Scholar]
  • Willard, S.S., Koochekpour, S. (2013). Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications. Int J Biol Sci, 9, 728-742. [CrossRef] [PubMed] [Google Scholar]
  • Willems, L., Jacque, N., Jacquel, A., Neveux, N., Trovati Maciel, T., Lambert, M., Schmitt, A., Poulain, L., Green, A.S., Uzunov, M., Kosmider, O., Radford-Weiss, I., Moura, I.C., Auberger, P., Ifrah, N., Bardet, V., Chapuis, N., Lacombe, C., Mayeux, P., Tamburini, J., Bouscary, D. (2013). Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood, 122, 3521-3532. [Google Scholar]
  • Wise, D.R., Thompson, C.B. (2010). Glutamine Addiction: A New Therapeutic Target in Cancer. Trends Biochem Sci, 35, 427-433. [CrossRef] [PubMed] [Google Scholar]
  • Wu, C.-S., Lu, Y.-J., Li, H.-P., Hsueh, C., Lu, C.-Y., Leu, Y.-W., Liu, H.-P., Lin, K.-H., Hui-Ming Huang, T., Chang, Y.-S. (2010). Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer, 126, 2542-2552. [PubMed] [Google Scholar]
  • Xiang, Y., Stine, Z.E., Xia, J., Lu, Y., O’Connor, R.S., Altman, B.J., Hsieh, A.L., Gouw, A.M., Thomas, A.G., Gao, P., Sun, L., Song, L., Yan, B., Slusher, B.S., Zhuo, J., Ooi, L.L., Lee, C.G.L., Mancuso, A., McCallion, A.S., Le, A., Milone, M.C., Rayport, S., Felsher, D.W., Dang, C.V. (2015). Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest, 125, 2293-2306. [PubMed] [Google Scholar]
  • Xu, W., Koeck, T., Lara, A.R., Neumann, D., DiFilippo, F.P., Koo, M., Janocha, A.J., Masri, F.A., Arroliga, A.C., Jennings, C., Dweik, R.A., Tuder, R.M., Stuehr, D.J., Erzurum, S.C. (2007). Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci USA, 104, 1342-1347. [CrossRef] [Google Scholar]
  • Yamada, H., Otsuka, M., Hayashi, M., Nakatsuka, S., Hamaguchi, K., Yamamoto, A., Moriyama, Y. (2001). Ca2+-dependent exocytosis of L-glutamate by alphaTC6, clonal mouse pancreatic alpha-cells. Diabetes, 50, 1012-1020. [PubMed] [Google Scholar]
  • Yamaguchi, F., Hirata, Y., Akram, H., Kamitori, K., Dong, Y., Sui, L., Tokuda, M. 2013. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer, 13, 468. [CrossRef] [PubMed] [Google Scholar]
  • Yeager, M.E., Halley, G.R., Golpon, H.A., Voelkel, N.F., Tuder, R.M. (2001). Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res, 88, E2-E11. [Google Scholar]
  • Yoo, B.C., Jeon, E., Hong, S.-H., Shin, Y.-K., Chang, H.J., Park, J.-G. (2004). Metabotropic Glutamate Receptor 4-Mediated 5-Fluorouracil Resistance in a Human Colon Cancer Cell Line. Clin Cancer Res, 10, 4176-4184. [CrossRef] [PubMed] [Google Scholar]
  • Yoshioka, A., Ikegaki, N., Williams, M., Pleasure, D. (1996). Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. J Neurosci Res, 46, 164-178. [CrossRef] [PubMed] [Google Scholar]
  • Yu, L.J., Wall, B.A., Wangari-Talbot, J., Chen, S. (2016).Metabotropic glutamate receptors in cancer. Neuropharmacology, doi:10.1016/j.neuropharm.2016.02.011. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.